| Trademark Snap Shot Amendment & Mail Processing Stylesheet (Table presents the data on Amendment & Mail Processing Complete) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88221046 | FILING DATE | 12/07/2018 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | TM ATTORNEY NOT ASSIGNED | L.O. ASSIGNED | NONE |
PUB INFORMATION |
|||
| RUN DATE | 12/21/2018 | ||
| PUB DATE | N/A | ||
| STATUS | 630-NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER | ||
| STATUS DATE | 12/11/2018 | ||
| LITERAL MARK ELEMENT | XIPERE | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | NO |
| LITERAL MARK ELEMENT | XIPERE |
| MARK DRAWING CODE | |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Clearside Biomedical, Inc. |
| ADDRESS | 900 North Point Parkway, Suite 200 Alpharetta, GA 30005 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Ocular pharmaceuticals; Ophthalmic preparations |
| INTERNATIONAL CLASS | 010 |
| DESCRIPTION TEXT | Medical devices, namely, a needle-based injection system for delivery of pharmaceuticals and injection needles; Ophthalmic medical devices, namely, a needle-based injection system for delivery of pharmaceuticals to eye tissue and injection needles; drug delivery systems |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 010 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| DESCRIPTION OF MARK | The mark consists of the word XIPERE beginning with a capital "X" followed by the capital letter "I" with an arc-like line beginning at the bottom of the letter I and continuing through the center of the letters P, E, and ending at the bottom of the letter R followed by a capital "E". |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 12/20/2018 | AMPX | O | APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 004 |
| 12/20/2018 | ALIE | A | ASSIGNED TO LIE | 003 |
| 12/18/2018 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | 002 |
| 12/11/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Bassam N. Ibrahim |
| CORRESPONDENCE ADDRESS | BASSAM N. IBRAHIM BUCHANAN INGERSOLL & ROONEY, PC 1737 KING STREET, SUITE 500 ALEXANDRIA, VA 22314 |
| DOMESTIC REPRESENTATIVE | NONE |